Mathematical Modeling of the HIV Transmission Risk After Initiation of Antiretroviral Therapy in naïve HIV-infected
NCT03183154 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1831
Last updated 2017-06-12
Summary
The objective of this study is to explore the impact of initiation of ART with different regimens in naïve MSM (in the setting of acute and chronic HIV-infection) on the probability of transmission of HIV by mathematical modeling.
Conditions
Interventions
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
University of California, Los Angeles
collaborator OTHER -
J Parrondo Health
collaborator UNKNOWN -
Fundación para la Investigación Biomédica del Hospital Gregorio Maranon
collaborator OTHER -
Hospital General Universitario Gregorio Marañon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-01
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
NCT01417949 ·Status: COMPLETED ·Phase: PHASE4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
NCT02656511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort
NCT06107140 ·Status: COMPLETED
-
Analytical Treatment Interruption in HIV Positive Patients
NCT02590354 ·Status: COMPLETED ·Phase: NA
-
Treatment De-Intensification and Residual HIV-1 in Youth
NCT00867854 ·Status: COMPLETED
-
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF
NCT01252940 ·Status: COMPLETED ·Phase: PHASE3
-
Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
NCT02611895 ·Status: COMPLETED ·Phase: NA
-
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
NCT00685191 ·Status: COMPLETED ·Phase: PHASE4
-
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
NCT01245101 ·Status: TERMINATED ·Phase: PHASE4
-
Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
NCT00355251 ·Status: TERMINATED ·Phase: PHASE4
-
Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
NCT00562510 ·Status: TERMINATED ·Phase: PHASE3
-
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
NCT02415595 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
NCT01266902 ·Status: COMPLETED ·Phase: PHASE3
-
Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression
NCT02491242 ·Status: COMPLETED
-
The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection
NCT05606055 ·Status: COMPLETED ·Phase: PHASE4
-
Intermittent ART in Primary HIV Infection
NCT02300623 ·Status: COMPLETED ·Phase: PHASE4
-
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
NCT01295515 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
NCT00532168 ·Status: COMPLETED ·Phase: PHASE4
-
Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
NCT00627055 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
NCT03405935 ·Status: COMPLETED ·Phase: PHASE3
-
Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia
NCT01378910 ·Status: COMPLETED ·Phase: PHASE4
-
Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antiretroviral Therapy in HIV Patients
NCT02039921 ·Status: COMPLETED
-
Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen
NCT02577042 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
NCT04720742 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Comparison of Two Anti-HIV Treatment Plans
NCT00005915 ·Status: COMPLETED